Swedbank AB Sells 4,951 Shares of Molina Healthcare, Inc $MOH

Swedbank AB reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 3.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 122,039 shares of the company’s stock after selling 4,951 shares during the quarter. Swedbank AB’s holdings in Molina Healthcare were worth $16,268,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. AQR Capital Management LLC increased its holdings in Molina Healthcare by 217.0% during the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after purchasing an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Molina Healthcare by 10.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after purchasing an additional 201,772 shares in the last quarter. Invesco Ltd. boosted its position in shares of Molina Healthcare by 24.2% during the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after buying an additional 329,679 shares during the period. Victory Capital Management Inc. boosted its position in shares of Molina Healthcare by 46.4% during the fourth quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after buying an additional 447,078 shares during the period. Finally, 8 Knots Management LLC bought a new position in shares of Molina Healthcare during the fourth quarter worth about $198,942,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is currently owned by insiders.

Molina Healthcare Stock Up 0.6%

MOH stock opened at $232.23 on Friday. The company has a market cap of $12.10 billion, a price-to-earnings ratio of 68.71 and a beta of 0.74. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $243.50. The business has a 50 day moving average price of $198.58 and a two-hundred day moving average price of $172.67. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. The company had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business’s revenue was down 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on MOH shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research report on Friday, April 24th. Morgan Stanley raised their price target on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 4th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a report on Wednesday, April 29th. Robert W. Baird boosted their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Finally, JPMorgan Chase & Co. increased their target price on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus target price of $185.88.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.